ACCURAY INC (ARAY) Stock Price & Overview
NASDAQ:ARAY • US0043971052
Current stock price
The current stock price of ARAY is 0.4153 USD. Today ARAY is up by 6.82%. In the past month the price decreased by -18.05%. In the past year, price decreased by -73.55%.
ARAY Key Statistics
- Market Cap
- 49.329M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.26
- Dividend Yield
- N/A
ARAY Stock Performance
ARAY Stock Chart
ARAY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ARAY. When comparing the yearly performance of all stocks, ARAY is a bad performer in the overall market: 97.15% of all stocks are doing better.
ARAY Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ARAY. Both the profitability and financial health of ARAY have multiple concerns.
ARAY Earnings
On February 4, 2026 ARAY reported an EPS of -0.11 and a revenue of 102.24M. The company beat EPS expectations (1.96% surprise) and missed revenue expectations (-0.61% surprise).
ARAY Forecast & Estimates
8 analysts have analysed ARAY and the average price target is 2.58 USD. This implies a price increase of 520.15% is expected in the next year compared to the current price of 0.4153.
For the next year, analysts expect an EPS growth of -902.41% and a revenue growth -2.54% for ARAY
ARAY Groups
Sector & Classification
ARAY Financial Highlights
Over the last trailing twelve months ARAY reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS decreased by -418% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.95% | ||
| ROE | -66.68% | ||
| Debt/Equity | 2.34 |
ARAY Ownership
ARAY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ARAY
Company Profile
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Company Info
IPO: 2007-02-08
ACCURAY INC
1240 Deming Way
Madison WISCONSIN 94089 US
CEO: Joshua H. Levine
Employees: 990
Phone: 18009279800
ACCURAY INC / ARAY FAQ
What does ARAY do?
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Can you provide the latest stock price for ACCURAY INC?
The current stock price of ARAY is 0.4153 USD. The price increased by 6.82% in the last trading session.
What is the dividend status of ACCURAY INC?
ARAY does not pay a dividend.
What is the ChartMill technical and fundamental rating of ARAY stock?
ARAY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for ARAY stock?
8 analysts have analysed ARAY and the average price target is 2.58 USD. This implies a price increase of 520.15% is expected in the next year compared to the current price of 0.4153.
Is ACCURAY INC (ARAY) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ARAY.
Can you provide the short interest for ARAY stock?
The outstanding short interest for ACCURAY INC (ARAY) is 5.81% of its float.